Literature DB >> 22982774

Pregnane X receptor mediated-transcription regulation of CYP3A by glycyrrhizin: a possible mechanism for its hepatoprotective property against lithocholic acid-induced injury.

Yu-Guang Wang1, Jian-Ming Zhou, Zeng-Chun Ma, Hua Li, Qian-De Liang, Hong-Ling Tan, Cheng-Rong Xiao, Bo-Li Zhang, Yue Gao.   

Abstract

Licorice (LE) has been commonly used in traditional Chinese medicine (TCM) for over 4000 years to reconcile various drugs and for hepatic disorders. Glycyrrhizin is the main bioactive component isolated from LE herbs. In the present study we examined the effects of glycyrrhizin on pregnane X receptor (PXR)-mediated CYP3A expression and its hepatoprotective activity. Treatment of HepG2 cells with glycyrrhizin resulted in marked increase in both CYP3A4 mRNA and protein levels. The transcriptional activation of the CYP3A4 gene through glycyrrhizin is PXR-dependent, as shown in transient transfection experiments. Glycyrrhizin activates the DNA-binding capacity of the PXR for the CYP3A4 element responding to xenobiotic signals, as measured by the electrophoretic-mobility shift assay (EMSA). These results indicate that the induction of the hepatic CYP3A4 by glycyrrhizin is mediated through the activation of PXR. The next aim of the current study was to determine whether the activation of PXR and induction of CYP3A by glycyrrhizin prevents hepatotoxicity during cholestasis as a mechanism of hepatoprotection. Mice were pretreated with glycyrrhizin prior to induction of intrahepatic cholestasis using lithocholic acid (LCA). Pre-treatment with glycyrrhizin, as well as the PXR activator pregnenolone 16α-carbontrile (PCN), prevents the increase in plasma ALT and AST activity, multifocal necrosis and prevents an increase in a level of serum LCA level in mice, as compared with the results in the mice treated with LCA alone. Activation of the PXR by glycyrrhizin results in induction of CYP3A11 (CYP3A4 for human) expression and inhibition of CYP7A1 through an increase in small heterodimer partner (SHP) expression. Glycyrrhizin regulates the expression of the gene mentioned above to prevent toxic accumulation of bile acids in the liver and it also protects mouse livers from the harmful effects of LCA. In conclusion, PXR-mediated effects on CYP3A and CYP7A may contribute to the hepatoprotective property of glycyrrhizin against LCA-induced liver injury. Crown
Copyright © 2012. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22982774     DOI: 10.1016/j.cbi.2012.08.023

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  12 in total

1.  Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation.

Authors:  Tingting Yan; Hong Wang; Lijuan Cao; Qiong Wang; Shogo Takahashi; Tomoki Yagai; Guolin Li; Kristopher W Krausz; Guangji Wang; Frank J Gonzalez; Haiping Hao
Journal:  Drug Metab Dispos       Date:  2018-06-29       Impact factor: 3.922

2.  The influence of bile acids homeostasis by cryptotanshinone-containing herbs.

Authors:  Chengcheng Gao; Tianheng Ma; Liqun Pang; Rui Xie
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

3.  Glycyrrhizin and glycyrrhetinic acid inhibits alpha-naphthyl isothiocyanate-induced liver injury and bile acid cycle disruption.

Authors:  Haina Wang; Zhong-Ze Fang; Ran Meng; Yun-Feng Cao; Naoki Tanaka; Kristopher W Krausz; Frank J Gonzalez
Journal:  Toxicology       Date:  2017-05-24       Impact factor: 4.221

4.  Schisandrol B protects against cholestatic liver injury through pregnane X receptors.

Authors:  Hang Zeng; Yiming Jiang; Pan Chen; Xiaomei Fan; Dongshun Li; Aiming Liu; Xiaochao Ma; Wen Xie; Peiqing Liu; Frank J Gonzalez; Min Huang; Huichang Bi
Journal:  Br J Pharmacol       Date:  2017-03-16       Impact factor: 8.739

5.  Ginkgolide B protects human umbilical vein endothelial cells against xenobiotic injuries via PXR activation.

Authors:  Tao Zhou; Wen-ting You; Zeng-chun Ma; Qian-de Liang; Hong-ling Tan; Cheng-rong Xiao; Xiang-lin Tang; Bo-li Zhang; Yu-guang Wang; Yue Gao
Journal:  Acta Pharmacol Sin       Date:  2016-01-18       Impact factor: 6.150

6.  Ophiopogonin D maintains Ca2+ homeostasis in rat cardiomyocytes in vitro by upregulating CYP2J3/EETs and suppressing ER stress.

Authors:  Wen-ting You; Tao Zhou; Zeng-chun Ma; Qian-de Liang; Cheng-rong Xiao; Xiang-lin Tang; Hong-ling Tan; Bo-li Zhang; Yu-guang Wang; Yue Gao
Journal:  Acta Pharmacol Sin       Date:  2016-02-01       Impact factor: 6.150

Review 7.  Updates on the clinical evidenced herb-warfarin interactions.

Authors:  Beikang Ge; Zhen Zhang; Zhong Zuo
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-18       Impact factor: 2.629

8.  Influences of Realgar-Indigo naturalis, A Traditional Chinese Medicine Formula, on the Main CYP450 Activities in Rats Using a Cocktail Method.

Authors:  Huan-Hua Xu; Fei-Ran Hao; Mei-Xi Wang; Si-Jia Ren; Ming Li; Hong-Ling Tan; Yu-Guang Wang; Xiang-Lin Tang; Cheng-Rong Xiao; Qian-De Liang; Yue Gao; Zeng-Chun Ma
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-21       Impact factor: 2.629

Review 9.  Glycyrrhizic acid as a multifunctional drug carrier - From physicochemical properties to biomedical applications: A modern insight on the ancient drug.

Authors:  O Yu Selyutina; N E Polyakov
Journal:  Int J Pharm       Date:  2019-01-25       Impact factor: 5.875

10.  Chaihu-Shugan-San Reinforces CYP3A4 Expression via Pregnane X Receptor in Depressive Treatment of Liver-Qi Stagnation Syndrome.

Authors:  Zehui He; Rong Fan; Chunhu Zhang; Tao Tang; Xu Liu; Jiekun Luo; Hanjin Cui; Yang Wang; Ruohuang Lu; Pingping Gan
Journal:  Evid Based Complement Alternat Med       Date:  2019-10-31       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.